Signia Styletto AX and New Augmented Xperience (AX) Platform Capabilities are Now Available to Veterans, Active Military Members, and Native Americans

Delivering the Freedom to Experience Optimized Hearing and Improved Health and Wellness

Signia today announced its new Styletto AX hearing aid and two new capabilities for its Augmented Xperience (AX) platform — My WellBeing and CallControl — are now available to U.S. Department of Veterans Affairs (VA) audiologists treating military veterans, as well as audiologists within the U.S. Department of Defense (DoD), for active military members, and the Indian Health Service (IHS) for Native Americans.

In addition, for the first time, veterans with single-sided deafness can now be fitted with the Styletto form-factor thanks to the company’s new CROS Styletto AX.

Launched in September 2022, Styletto AX features the world’s first SLIM-RIC hearing aid with a slim and stylish design that breaks down stigma. Styletto AX — along with all hearing aids on the Augmented Xperience platform — features My WellBeing, a new capability that goes beyond better hearing to empower patients to stay healthy in mind and body, and CallControl, which gives patients the freedom to participate in other activities while taking phone calls using Signia HandsFree.

“Signia recognizes that many of our country’s veterans have hearing loss related to the contributions they made to secure our freedom. Now, it’s our turn show gratitude by providing veterans with life-changing solutions to live their lives to the fullest,” said John Murray, Signia’s vice president of Government Services. “With Styletto AX, we’re furthering our commitment to delivering innovative solutions, unparalleled support, and service excellence to Government Services audiologists and the veterans they serve.”

The My WellBeing feature actively tracks key health & wellness metrics such as level of social engagement (My Conversations), hearing aid wear-time consistency (My WearTime), number of steps taken (My Steps), and overall level of physical activity (My Activity).

Patients can use this information to enhance their lifestyles in ways that can improve their mental, emotional, and physical well-being. My WellBeing also encourages consistent hearing aid use by bringing awareness to just how significant healthy hearing is to maintaining overall health and wellness.

With CallControl, patients can use their Signia AX hearing aids to operate the Signia HandsFree feature with their iPhones or iPads via Bluetooth®. CallControl also uses the patented dual processing technology of Signia AX to reduce background noise during phone conversations to provide better clarity and intelligibility for patients in noisy environments.

Styletto AX joins the growing lineup of hearing aids built on Signia’s industry-leading AX platform, which uses groundbreaking Augmented Focus™ technology to uniquely process speech and background noise separately with two different processors — offering outstanding speech clarity in a fully immersive soundscape. Styletto AX is also available in 14 unique color combinations, including options exclusively for Government Services.

Furthermore, boasting up to 20 hours of runtime per charge, Styletto AX features a pocket-size charging case that charges the hearing aids wirelessly for up to four additional days, making the process extremely convenient and discreet. Patients can now charge their hearing aids anywhere, at home or on the go.

“We’re excited to provide Government Services audiologists with another revolutionary solution that combines several world’s-first technologies in an award-winning form-factor,” added Murray. “Styletto AX does more than just optimize hearing — it empowers veterans to enhance their lifestyles through improved health and wellness, from movement to socialization and beyond.”

Signia invites Government Services audiologists to join the live webinar to discuss the launch in more detail on November 1 at 12:30 p.m. EST and 12:30 p.m. MT. Click here to register and earn .5 CEUs.

SourceSignia

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.